Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. (Q38618657)

4 September 2017

1 reference

title

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. (English)

1 reference

4 September 2017

1 reference

4

Groop L

1 reference

4 September 2017

Melander A

1

1 reference

4 September 2017

Bitzén PO

series ordinal

2

1 reference

4 September 2017

Faber O

series ordinal

3

1 reference

4 September 2017

1 January 1989

1 reference

4 September 2017

1 reference

4 September 2017

37

1 reference

4 September 2017

1

1 reference

4 September 2017

58-72

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198937010-00004

4 September 2017

0 references

cites work

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

12 December 2020

Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids

1 reference

12 December 2020

Diet-Induced Improvement of Abnormalities in Insulin and Glucagon Secretion and in Insulin Receptor Binding in Diabetes Mellitus*

1 reference

12 December 2020

The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics

1 reference

12 December 2020

Appraisal of the Extrapancreatic Actions of Sulfonylureas

1 reference

12 December 2020

Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects.

1 reference

12 December 2020

Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus

1 reference

12 December 2020

Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

1 reference

12 December 2020

Efficacy of dietary regulation in primary health care patients with hyperglycaemia detected by screening.

1 reference

12 December 2020

The effects of glibenclamide and insulin on plasma high density lipoprotein in diabetics

1 reference

12 December 2020

Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

1 reference

12 December 2020

Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.

1 reference

12 December 2020

[The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984]

1 reference

12 December 2020

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs

1 reference

12 December 2020

Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.

1 reference

12 December 2020

Plasma levels of glibenclamide in diabetic patients during its routine clinical administration determined by a specific radioimmunoassay.

1 reference

12 December 2020

Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus

1 reference

12 December 2020

Sulfonylureas in the treatment of diabetes mellitus--1985.

1 reference

12 December 2020

Clinical pharmacology of sulfonylureas

1 reference

12 December 2020

Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy

1 reference

12 December 2020

The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal

1 reference

12 December 2020

Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics

1 reference

12 December 2020

Therapeutic equivalence of once- and thrice-daily glipizide.

1 reference

12 December 2020

Impaired effect of sulfonylurea following increased dosage.

1 reference

12 December 2020

Drug-induced reversal of early diabetic microangiopathy

1 reference

12 December 2020

Do sulfonylureas influence hepatic insulin clearance?

1 reference

12 December 2020

A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in Type 2 (non-insulin-dependent) diabetes

1 reference

12 December 2020

Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control

1 reference

12 December 2020

Diabetic microangiopathy and the control of blood glucose

1 reference

12 December 2020

New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus

1 reference

12 December 2020

The crux of the UGDP. Spurious results and biologically inappropriate data analysis

1 reference

12 December 2020

Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes

1 reference

12 December 2020

Mechanism of improvement in glucose metabolism after chronic glyburide therapy

1 reference

12 December 2020

Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up

1 reference

12 December 2020

Severe drug-induced hypoglycemia: a review

1 reference

12 December 2020

Sulphonylureas and hypoglycaemia

1 reference

12 December 2020

Insulin-independent diabetes mellitus: metabolic characteristics

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Glipizide for reversal of early diabetic microangiopathy

1 reference

12 December 2020

Comparison on sulphonylurea and insulin treatment on lipid levels in maturity-onset diabetic men and women

1 reference

12 December 2020

Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects

1 reference

12 December 2020

Augmentation of the effects of insulin and insulin-like growth factors I and II on glucose uptake in cultured rat skeletal muscle cells by sulfonylureas

1 reference

12 December 2020

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

12 December 2020

Effect of glyburide in type II diabetes mellitus. Studies of monocyte membrane fluidity, lipid composition, and insulin binding.

1 reference

12 December 2020

Interindividual variation in the absorption of glibenclamide in man.

1 reference

12 December 2020

Improved effect of glibenclamide on administration before breakfast.

1 reference

12 December 2020

Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.

1 reference

12 December 2020

Antidiabetic Drugs After the University Group Diabetes Program (UGDP)

1 reference

12 December 2020

Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy

1 reference

12 December 2020

Interaction of ethanol and glipizide in humans

1 reference

12 December 2020

The antidiabetic effect and pharmacokinetic properties of glipizide. Comparison of a single dose with divided dose regime.

1 reference

12 December 2020

On the pathogenesis of maturity-onset diabetes

1 reference

12 December 2020

Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients

1 reference

12 December 2020

Effects of glipizide on the insulin production by isolated mouse pancreatic islets

1 reference

12 December 2020

Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects

1 reference

12 December 2020

Glucose and Insulin Secretory Response Patterns Following Diet and Tolazamide Therapy in Diabetes

1 reference

12 December 2020

Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes.

1 reference

12 December 2020

Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in β-cell-rich pancreatic islets

1 reference

12 December 2020

The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes.

1 reference

12 December 2020

Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues

1 reference

12 December 2020

Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide

1 reference

12 December 2020

Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

1 reference

12 December 2020

Influence of sulfonylureas on the secretion, disposal and effect of insulin.

1 reference

12 December 2020

Lipoprotein composition in diabetes mellitus

1 reference

12 December 2020

Clinical pharmacology of oral antidiabetic agents (second of two parts).

1 reference

12 December 2020

Assessment of laboratory methods for detection of unsuspected diabetes in primary health care.

1 reference

12 December 2020

Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.

1 reference

12 December 2020

Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.

1 reference

12 December 2020

Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics

1 reference

12 December 2020

The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide

1 reference

12 December 2020

Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion

1 reference

12 December 2020

Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

1 reference

12 December 2020

Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds

1 reference

12 December 2020

UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year

1 reference

12 December 2020

Direct effects of sulfonylurea agents on glucose transport in the BC3H-1 myocyte

1 reference

12 December 2020

Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

1 reference

12 December 2020

Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects

1 reference

12 December 2020

Value of glucose control in preventing complications of diabetes

1 reference

12 December 2020

Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs

1 reference

12 December 2020

Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM

1 reference

12 December 2020

Diabetes: The quest for basal normoglycaemia

1 reference

12 December 2020

Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics.

1 reference

12 December 2020

An evaluation of the effects of some sulphonylureas on platelet function

1 reference

12 December 2020

[Glibenclamide-insulin combination in the management of secondary failure of sulfonyl-urea medication]

1 reference

12 December 2020

Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus. Combined effects

1 reference

12 December 2020

Improved effect of tolbutamide when given before food in patients on long-term therapy.

1 reference

12 December 2020

Insulin secretion and clearance. Comparison after oral and intravenous glucose.

1 reference

12 December 2020

Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics

1 reference

12 December 2020

The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes

1 reference

12 December 2020

Effects of dietary changes on cellular insulin binding and in vivo insulin sensitivity

1 reference

12 December 2020

Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes.

1 reference

12 December 2020

The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.

1 reference

12 December 2020

High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes

1 reference

12 December 2020

10.2165/00003495-198937010-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

0 references

1 reference